← FDA Drug Approvals (Drugs@FDA)
OXCARBAZEPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA LTD · Approved 2025-01-08
Drug application
- FDA Application #
ANDA218442- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXCARBAZEPINE
- Generic name
- Oxcarbazepine
- Active ingredients
- OXCARBAZEPINE
- Dosage form
- TABLET
- Route
- EXTENDED RELEASE
- Marketing status
- None (Tentative Approval)
- Sponsor
- BIOCON PHARMA LTD
- First approval
- 2025-01-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown